ITRON, INC. (ITRI)
Instruments For Meas & Testing of Electricity & Elec Signals · Healthcare · $3.6B
Intrinsic Value (Consensus)
$89.46
Current Price
$81.10
Margin of Safety
+10.3%
10.3% Below Intrinsic Value
Value: $89
Price: $81
Valuation Model Estimates
Current Price: $81.10
DCF (Discounted Cash Flow)
$405.30
Graham Number
$75.26
Earnings Power Value
$63.11
Relative Value (P/E)
$130.00
Dividend Discount Model
Not applicable
—
Consensus Value
$89.46
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
66
Profitability
22/25
Strength
19/25
Valuation
15/25
Growth
10/25
Financial Health Signals
Declining revenue — top line is shrinking
Strong earnings growth (20% YoY)
High free cash flow yield (10.7%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $6.50
- EPS (Forward)
- $7.80
- Book Value
- $38.73
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 17.5%
- Debt/Equity
- 74%
- Revenue Growth
- -3.0%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance